WALTHAM, Mass. and BOULDER, Colo., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined ...
Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that it will ...
Hosted on MSN
IMRC 2025 concludes at IIMA with high-impact discussions, poster presentations, and diverse research perspectives
India, Dec. 7 -- ~ The concluding day featured a conference-wide poster presentation session, where over 80 participants presented their research across diverse areas of management The Indian ...
BBOT is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies. BBOT has the goal of improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback